PubMed:10077156
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 44-54 | cell_type | denotes | neutrophil |
| T2 | 171-181 | cell_type | denotes | neutrophil |
| T3 | 340-367 | protein | denotes | tumor necrosis factor-alpha |
| T4 | 416-439 | protein | denotes | glucocorticoid receptor |
| T5 | 552-566 | protein | denotes | beta2 integrin |
| T6 | 574-584 | cell_type | denotes | neutrophil |
| T7 | 628-638 | cell_type | denotes | neutrophil |
| T8 | 693-703 | cell_type | denotes | neutrophil |
| T9 | 859-869 | cell_type | denotes | neutrophil |
| T10 | 974-988 | protein | denotes | beta2 integrin |
| T11 | 996-1006 | cell_type | denotes | neutrophil |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 38-85 | NP | denotes | human neutrophil-mediated tumor cell cytostasis |
| C2 | 171-212 | NP | denotes | neutrophil-mediated tumor cell cytostasis |
| C3 | 247-266 | NP | denotes | a synthetic hormone |
| C4 | 268-287 | NP | denotes | dexamethasone (Dex) |
| C5 | 383-386 | NP | denotes | Dex |
| C6 | 414-450 | NP | denotes | a glucocorticoid receptor antagonist |
| C7 | 452-459 | NP | denotes | RU38486 |
| C9 | 522-525 | NP | denotes | Dex |
| C10 | 552-566 | NP | denotes | beta2 integrin |
| C11 | 570-592 | NP | denotes | the neutrophil surface |
| C8 | 511-592 | NP | denotes | effects of Dex on the binding avidity of beta2 integrin on the neutrophil surface |
| C12 | 601-606 | NP | denotes | these |
| C13 | 662-665 | NP | denotes | Dex |
| C14 | 720-727 | NP | denotes | RU38486 |
| C15 | 859-900 | NP | denotes | neutrophil-mediated tumor cell cytostasis |
| C16 | 974-988 | NP | denotes | beta2 integrin |
| C17 | 992-1014 | NP | denotes | the neutrophil surface |
| R1 | C2 | C1 | coref-ident | neutrophil-mediated tumor cell cytostasis,human neutrophil-mediated tumor cell cytostasis |
| R2 | C4 | C3 | coref-appos | dexamethasone (Dex),a synthetic hormone |
| R3 | C5 | C3 | coref-ident | Dex,a synthetic hormone |
| R4 | C7 | C6 | coref-appos | RU38486,a glucocorticoid receptor antagonist |
| R5 | C9 | C5 | coref-ident | Dex,Dex |
| R6 | C12 | C8 | coref-pron | these,effects of Dex on the binding avidity of beta2 integrin on the neutrophil surface |
| R7 | C13 | C9 | coref-ident | Dex,Dex |
| R8 | C14 | C6 | coref-ident | RU38486,a glucocorticoid receptor antagonist |
| R9 | C15 | C2 | coref-ident | neutrophil-mediated tumor cell cytostasis,neutrophil-mediated tumor cell cytostasis |
| R10 | C16 | C10 | coref-ident | beta2 integrin,beta2 integrin |
| R11 | C17 | C11 | coref-ident | the neutrophil surface,the neutrophil surface |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-86 | Sentence | denotes | Glucocorticoid hormone suppression of human neutrophil-mediated tumor cell cytostasis. |
| S2 | 87-368 | Sentence | denotes | In the present study, we have investigated the effect of glucocorticoid hormones on neutrophil-mediated tumor cell cytostasis and found that hydrocortisone and a synthetic hormone, dexamethasone (Dex), inhibited cytostasis in the presence or absence of tumor necrosis factor-alpha. |
| S3 | 369-460 | Sentence | denotes | The effect of Dex was completely reversed by a glucocorticoid receptor antagonist, RU38486. |
| S4 | 461-661 | Sentence | denotes | To clarify the underlying mechanisms, we examined effects of Dex on the binding avidity of beta2 integrin on the neutrophil surface and how these might in turn affect neutrophil-to-tumor cell binding. |
| S5 | 662-779 | Sentence | denotes | Dex was found to inhibit these neutrophil properties, and RU38486 completely suppressed both forms of Dex inhibition. |
| S6 | 780-1015 | Sentence | denotes | Taken together, our findings suggest that glucocorticoid hormone inhibition of neutrophil-mediated tumor cell cytostasis is at least partially due to a lowering of the ligand binding avidity of beta2 integrin on the neutrophil surface. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-34 | other_name | denotes | Glucocorticoid hormone suppression |
| T2 | 38-43 | other_name | denotes | human |
| T3 | 44-54 | cell_type | denotes | neutrophil |
| T4 | 144-167 | lipid | denotes | glucocorticoid hormones |
| T5 | 171-181 | cell_type | denotes | neutrophil |
| T6 | 228-242 | lipid | denotes | hydrocortisone |
| T7 | 249-266 | lipid | denotes | synthetic hormone |
| T8 | 268-281 | lipid | denotes | dexamethasone |
| T9 | 283-286 | lipid | denotes | Dex |
| T10 | 340-367 | protein_molecule | denotes | tumor necrosis factor-alpha |
| T11 | 383-386 | lipid | denotes | Dex |
| T12 | 416-439 | protein_family_or_group | denotes | glucocorticoid receptor |
| T13 | 452-459 | other_organic_compound | denotes | RU38486 |
| T14 | 476-497 | other_name | denotes | underlying mechanisms |
| T15 | 522-525 | lipid | denotes | Dex |
| T16 | 552-566 | protein_molecule | denotes | beta2 integrin |
| T17 | 574-584 | cell_type | denotes | neutrophil |
| T18 | 616-627 | other_name | denotes | turn affect |
| T19 | 628-638 | cell_type | denotes | neutrophil |
| T20 | 662-665 | lipid | denotes | Dex |
| T21 | 693-703 | cell_type | denotes | neutrophil |
| T22 | 720-727 | other_organic_compound | denotes | RU38486 |
| T23 | 764-767 | lipid | denotes | Dex |
| T24 | 822-855 | other_name | denotes | glucocorticoid hormone inhibition |
| T25 | 859-869 | cell_type | denotes | neutrophil |
| T26 | 948-970 | other_name | denotes | ligand binding avidity |
| T27 | 974-988 | protein_molecule | denotes | beta2 integrin |
| T28 | 996-1006 | cell_type | denotes | neutrophil |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 191-196 | HP_0002664 | denotes | tumor |
| T2 | 340-345 | HP_0002664 | denotes | tumor |
| T3 | 642-647 | HP_0002664 | denotes | tumor |
| T4 | 879-884 | HP_0002664 | denotes | tumor |